252 related articles for article (PubMed ID: 6481185)
1. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E.
Hatheway CH; Snyder JD; Seals JE; Edell TA; Lewis GE
J Infect Dis; 1984 Sep; 150(3):407-12. PubMed ID: 6481185
[TBL] [Abstract][Full Text] [Related]
2. Attempts to quantity Clostridium botulinum type A toxin and antitoxin in serum of two cases of infant botulism in Japan.
Takahashi M; Noda H; Takeshita S; Fujiwara T; Nakanoin H; Mizunoya T; Sakaguchi G
Jpn J Med Sci Biol; 1990 Dec; 43(6):233-7. PubMed ID: 2101138
[TBL] [Abstract][Full Text] [Related]
3. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.
Tacket CO; Shandera WX; Mann JM; Hargrett NT; Blake PA
Am J Med; 1984 May; 76(5):794-8. PubMed ID: 6720725
[TBL] [Abstract][Full Text] [Related]
4. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
Fan KL; Wang YL; Chu G; Leung LP
J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model.
Emanuel A; Qiu H; Barker D; Takla T; Gillum K; Neimuth N; Kodihalli S
PLoS One; 2019; 14(1):e0209019. PubMed ID: 30633746
[TBL] [Abstract][Full Text] [Related]
6. Persistence of botulinum toxin in patients' serum: Alaska, 1959-2007.
Fagan RP; McLaughlin JB; Middaugh JP
J Infect Dis; 2009 Apr; 199(7):1029-31. PubMed ID: 19203262
[TBL] [Abstract][Full Text] [Related]
7. [Serotherapy of botulism].
Nikiforov VN; Glukhikh OA; Nikiforov VV; Rezepov FF; Akhizova TIa
Sov Med; 1986; (9):44-7. PubMed ID: 3798222
[No Abstract] [Full Text] [Related]
8. Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation - A Descriptive Series of Patient Features and Outcome.
Rashid EAMA; El-Mahdy NM; Kharoub HS; Gouda AS; ElNabarawy NA; Mégarbane B
Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):622-627. PubMed ID: 29786953
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Botulism and Use of Equine Botulinum Antitoxin in Children: A Systematic Review.
Griese SE; Kisselburgh HM; Bartenfeld MT; Thomas E; Rao AK; Sobel J; Dziuban EJ
Clin Infect Dis; 2017 Dec; 66(suppl_1):S17-S29. PubMed ID: 29293924
[TBL] [Abstract][Full Text] [Related]
11. [A patient with botulism caused by Clostridium botulinum type B].
Postma TJ; Hazenberg GJ; Driessen JJ; Faes TJ
Ned Tijdschr Geneeskd; 1989 Oct; 133(43):2137-40. PubMed ID: 2812105
[TBL] [Abstract][Full Text] [Related]
12. Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT
Parrera GS; Astacio H; Tunga P; Anderson DM; Hall CL; Richardson JS
Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050996
[TBL] [Abstract][Full Text] [Related]
13. A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model.
Mukherjee J; Tremblay JM; Leysath CE; Ofori K; Baldwin K; Feng X; Bedenice D; Webb RP; Wright PM; Smith LA; Tzipori S; Shoemaker CB
PLoS One; 2012; 7(1):e29941. PubMed ID: 22238680
[TBL] [Abstract][Full Text] [Related]
14. Botulism.
Sobel J
Clin Infect Dis; 2005 Oct; 41(8):1167-73. PubMed ID: 16163636
[TBL] [Abstract][Full Text] [Related]
15. Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin.
Fagan RP; Neil KP; Sasich R; Luquez C; Asaad H; Maslanka S; Khalil W
Clin Infect Dis; 2011 Nov; 53(9):e125-8. PubMed ID: 21896700
[TBL] [Abstract][Full Text] [Related]
16. Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup-Allergic Reactions to Botulinum Antitoxin: A Systematic Review.
Schussler E; Sobel J; Hsu J; Yu P; Meaney-Delman D; Grammer LC; Nowak-Wegrzyn A
Clin Infect Dis; 2017 Dec; 66(suppl_1):S65-S72. PubMed ID: 29293931
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and epidemiological analysis of patients with botulism hospitalized at the Department of Infectious Disease, Medical University of Lublin in 1990-2000].
Bielec D; Semczuk G; Lis J; Firych J; Modrzewska R; Janowski R
Przegl Epidemiol; 2002; 56(3):435-42. PubMed ID: 12608093
[TBL] [Abstract][Full Text] [Related]
18. Two cases of foodborne botulism with home-preserved asparagus.
Zanon P; Pattis P; Pittscheider W; Roscia G; De Giorgi G; Sacco G; Vötter K; Stockner I; De Giorgi F; Wiedermann CJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Mar; 41(3):156-9. PubMed ID: 16557441
[TBL] [Abstract][Full Text] [Related]
19. [Botulism toxin, bioterrorist weapon].
Bossi P; Bricaire F
Presse Med; 2003 Mar; 32(10):463-5. PubMed ID: 12733311
[TBL] [Abstract][Full Text] [Related]
20. Wound botulism acquired in the Amazonian rain forest of Ecuador.
Reller ME; Douce RW; Maslanka SE; Torres DS; Manock SR; Sobel J
Am J Trop Med Hyg; 2006 Apr; 74(4):628-31. PubMed ID: 16606997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
